Markets:

Overview

News

Currencies

International

Treasuries

Insmed Incorporated - Common Stock (NQ:INSM)

107.91 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insmed Incorporated - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Insmed Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) ↗

February 11, 2025

Via Benzinga

Here's How Much You Would Have Made Owning Insmed Stock In The Last 5 Years ↗

February 05, 2025

Via Benzinga

Goldman Sachs Sees High Merger Odds For This Large-Cap Biopharma In Trump 2.0 Era: Retail Has Been Alert ↗

January 16, 2025

Insmed specializes in treatments for rare and serious diseases and is currently advancing its lead asset, brensocatib, a potential first-in-class therapy for bronchiectasis.

Via Stocktwits

Topics Government

How Is The Market Feeling About Insmed? ↗

January 13, 2025

Via Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

January 10, 2025

The Benzinga Stock Whisper Index looks at five stocks receiving increased attention from readers during the week and provides potential reason why.

Via Benzinga

Here's How Much You Would Have Made Owning Insmed Stock In The Last 10 Years ↗

January 02, 2025

Via Benzinga

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today ↗

December 16, 2024

Via Benzinga

How Is The Market Feeling About Insmed? ↗

December 03, 2024

Via Benzinga

Demystifying Insmed: Insights From 7 Analyst Reviews ↗

November 22, 2024

Via Benzinga

1 Vanguard Index Fund to Buy to Beat the S&P 500 in 2025, According to a Wall Street Bank ↗

December 17, 2024

Via The Motley Fool

Topics Stocks

1 Vanguard Index Fund May Beat the S&P 500 by 100% in the Next Few Years, According to a Wall Street Analyst ↗

November 20, 2024

Via The Motley Fool

Topics Stocks

Energizer, C3.ai, Insmed And Other Big Stocks Moving Higher On Tuesday ↗

November 19, 2024

Via Benzinga

Insmed's Options: A Look at What the Big Money is Thinking ↗

November 18, 2024

Via Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

November 08, 2024

The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the past week. Several of this week's stocks may have gotten a Trump bump.

Via Benzinga

Topics Government

A Glimpse of Insmed's Earnings Potential ↗

October 30, 2024

Via Benzinga

Here's How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today ↗

October 25, 2024

Via Benzinga

Peering Into Insmed's Recent Short Interest ↗

October 24, 2024

Via Benzinga

Here's How Much $100 Invested In Insmed 10 Years Ago Would Be Worth Today ↗

October 15, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Insmed Stock In The Last 10 Years ↗

September 20, 2024

Via Benzinga

(INSM) - Analyzing Insmed's Short Interest ↗

September 16, 2024

Via Benzinga

Here's How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today ↗

September 10, 2024

Via Benzinga

$1000 Invested In Insmed 10 Years Ago Would Be Worth This Much Today ↗

August 26, 2024

Via Benzinga

NASDAQ:INSM Shows Potential for a Breakout. ↗

August 26, 2024

INSMED INC (NASDAQ:INSM) Reveals Intriguing Technical Aspects. Here's What You Need to Know.

Via Chartmill

Good technical signals and a possible breakout for INSMED INC. ↗

August 20, 2024

NASDAQ:INSM Shows Potential for a Breakout.

Via Chartmill

$100 Invested In Insmed 5 Years Ago Would Be Worth This Much Today ↗

August 08, 2024

Via Benzinga

Meta Stock Leads 5 Names Near Buy Points As Market Bounces ↗

August 24, 2024

The major indexes rose strongly Friday on Fed Chair Jerome Powell's speech.

Via Investor's Business Daily

Topics Economy

INSM Stock Earnings: Insmed Misses EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

INSM stock results show that Insmed missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

A Russell 2000 Bull Market Is Coming: 1 Unstoppable Vanguard ETF to Buy Hand Over Fist ↗

July 31, 2024

Small-cap stocks are on fire in July, but the Russell 2000 is still in a technical bear market.

Via The Motley Fool

Topics ETFs

1 Historically Cheap Vanguard Index Fund to Buy Before It Soars 40%, According to a Wall Street Analyst ↗

July 29, 2024

Tom Lee at Fundstrat Global Advisors believes cheap valuations and interest rate cuts will send the Russell 2000 much higher by the end of the summer.

Via The Motley Fool

These Signs Show Which Stocks Are Having A Hidden Rally, Says Mark Minervini ↗

July 25, 2024

Meta stock and Insmed stock share characteristics that can help investors look for strong stocks even in weak markets.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.